University of Oklahoma researchers have deepened their understanding of a drug's ability to prevent fat buildup in the liver, a condition that often occurs with obesity and can lead to serious fatty liver disease. Their findings—which illustrate the complexity of metabolic disorders—are published in The Proceedings of the National Academy of Sciences.

Related Keywords

Lijie Gu , Jed Friedman , Tiangang Li , Proceedings Of The National Academy Sciences , Ou Health Harold Hamm Diabetes Center , University Of Oklahoma , Ou College Of Medicine , National Academy , Harold Hamm Diabetes Center ,